Systematic Reviews
Copyright ©The Author(s) 2015.
World J Diabetes. Jun 10, 2015; 6(5): 759-773
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.759
Table 2 General characteristics of studies of chronic kidney disease in people with diabetes in Africa
Ref.CountryPeriodDesignSettingSample sizeMean or median age (yr)Male (%)Type and duration of diabetes (yr)Duration FUPMethod for CKD assessment
ProteinuriaMDRDUrine ACRCockroft-Gault
Motala et al[37], 2001South AfricaNot precisedRetrospective cohort studyClinic, urban21939.5 T1DM; 58.4 T2DM19.616.10 T1DM; 18.6 T2DMAt least 10 yrpersistent proteinuria (Dipstick)
Elbagir et al[26], 1995SudanJan-July 1992Cross-sectional, self-selected samplingClinic, urban12831.5 (15-75)48.4Insulin-treated; 9 (1-40)NAProteinuria (Dipstick)
Sobngwi et al[44], 1999CameroonNot precisedCross-sectional, self-selected samplingClinic, urban6437.4 normotensive T1DM; 51.7 normotensive T2DM; 57.9 hypertensive T1DM57.86.7 normotensive T1DM; 4.7 normotensive T2DM; 4.8 hypertensive T1DMNAProteinuria
Katchunga et al[30], 2010DR congo2005-2007Cross-sectional, self-selected samplingClinic, urban9858 (10.4)35.77.3 T2DMNAMDRD (corrected for Blacks)
Choukem et al[22], 2012CameroonJan 2008- Oct 2010Cross-sectional, self-selected samplingClinic, urban42056.7494 (1-9) T2DMNAProteinuria (Dipstick)
Keeton et al[31], 2004South AfricaNot precisedProspective cohort, self-selected samplingClinic, urban596235.617.8 T2DM12 yrUrine ACR
Pruijm et al[39], 2008Seychelles2004Cross-sectional; random sex and age-stratified samplePopulation1218 (whole sample, including diabetic patients)Not precised45.9Newly diagnosed patientsNAUrine ACR
Alebiosu[16], 2003NigeriaJan 2000 June 2001Cross-sectional, self-selected samplingClinic, urban3426.5 T1DM; 9.4 T2DM53.826 T1DM; 53.4 T2DMNAPersistent proteinuria
Bouaziz et al[20], 2012TunisiaJan 2008Dec 2010Cross-sectional, self-selected samplingClinic, urban7359.323.3T2DM 10.6NAProteinuria
Ajayi et al[15], 2014NigeriaNot precisedRetrospective cross-sectionalClinic, urban65Not availableNot availableT2DMNAMDRD
Levitt et al[32], 1997South AfricaJuly-December 1992Cross-sectional, stratified random samplingClinic, urban24356.438.38 T2DM and T1DMNAPersistent proteinuriaUrine ACR
Majaliwa et al[34], 2007TanzaniaJune 2005- Feb 2006Cross-sectional, self-selected samplingClinic, urban9912.642.44.76 T1DMNAProteinuria
Marshall et al[36], 2013RwandaJune 2009-Nov 2010Cross-sectional, self-selected samplingClinic, urban28618.646.53.4 T1DMNAProteinuriaUrine ACR
Alebiosu et al[18], 2003NigeriaSept 1999- August 2002Cross-sectional, self-selected samplingClinic, urban465Not precisedNot precisedT2DMNAProteinuria
Gill et al[28], 2005South AfricaFrom 1982 to 2002Prospective cohort, self-selected samplingClinic, urban8822 at onset52T1DM20 yr
Djrolo et al[24], 2001BeninNot indicatedCross-sectionalClinic, urban15253.365.8T1DM and T2DMNAProteinuria
Rotchford et al[43], 2002South Africa1999Cross-sectional, self-selected samplingClinic, rural25356.526.942.2; T1DM and T2DMNAUrine ACR
Rissassi et al[42], 2009DR congo11 june 2008 to 30 july 2008Cross-sectional, self-selected samplingClinic, urban18119.138.757.6 T1DMNAUrine ACR
Rahlenbeck et al[40], 1997EthiopiaJanuary - April 1995Cross-sectional, self-selected samplingClinic, urban17031.4 T1DM; 56.7 T2DM605.9 T1DM; 6.0 T2DMNAProteinuria
Wanjohi et al[45], 2002KenyaJune 2000 - January 2001cross-sectional, self-selected samplingClinic, urban10053.73710.3 T2DMNAAlbuminuria
Nambuya et al[38], 1996Uganda1 January 1993 - 10 August 1994Cross-sectional, self-selected samplingClinic, urban/urban (origin of participants)252Not precised46.445 (range 30-69)T2DM and T1DMNAProteinuria
Rasmussen et al[41], 2013ZambiaFebruary - April 2011Cross-sectional, self-selected samplingClinic, rural10150 (range 50-68)37.3T2DM and T1DMNAUrine ACR
Bentata et al[19], 2013MoroccoFrom September 2006Prospective cohort studyClinic, urban7229.569.417 (11-20) T1DM5 yrProteinuriaMDRD
Gill et al[27], 2008EthiopiaNot precisedCross-sectional, self-selected samplingClinic, rural1054170.57 T1DM and T2DMNAUrine ACR
Bouzid et al[21], 2011TunisiaJune 2006 - July 2008Cross-sectional, self-selected samplingClinic, urban6896039.311 T2DMNAProteinuriaCockroft-Gault
Janmohamed et al[29], 2013TanzaniaOctober 2011 - March 2012Cross-sectional, self-selected samplingClinic, urban36954 (IQR 45-62)46.66 (3-11)T1DM (6.2%) and T2DM (93.8%)NACockroft-Gault
Danquah et al[23], 2012GhanaAugust 2007 - June 2008Cross-sectional, self-selected samplingClinic, urban67554.725T2DMNAProteinuria
Lutale et al[33], 2007TanzaniaJuly 2003 - March 2004Cross-sectional, self-selected samplingClinic, urban244T1DM 21(range 4-44.8)T2DM 53 (range 23.5-85)46.3T1DM 3 (0-17)T2DM 4 (range 0-25)NAProteinuriaCockroft-Gault
Worku et al[46], 2010EthiopiaOctober 2008Cross-sectional, self-selected samplingClinic, urban30544.462.9T1DM and T2DM; 53.4% less than 5 yr and 33.8% 5-9 yrNAProteinuria
Makulo et al[35], 2010DR Congo30 March - 24 April 2007Cross-sectional, self-selected samplingPopulation-based, Urban81Not precisedNot precisedNo precisionNAMDRDUrine ACR
Eghan et al[25], 2007GhanaJanuary - July 2005Cross-sectional, self-selected samplingClinic, urban10954.128T1DM and T2DM 10.7NAProteinuria
Alebiosu et al[17], 2004NigeriaJanuary 2000 - June 2001Case (T2DM with persistent proteinuria-control (T2DM patients nephropathy)Clinic, urban16253.450T2DM9.4 cases, 5.5 controlsNA